Search

everythinglearnresearchcommunity

for

Search:↓

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Connecting with supportive communities is crucial for healthcare professionals to address their own health and well-being.

I'm sorry, but there's no conclusion provided to summarize.

Ayurvedic treatment significantly reduced alopecia areata symptoms.

Traumatic anserine folliculosis is a harmless skin condition in young males that needs correct diagnosis to avoid unnecessary treatments.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Tacrolimus and corticosteroids can improve symptoms of Satoyoshi syndrome.

The combined treatments were highly effective for improving atrophic acne scars.

Children with atopic diseases have a higher risk of developing alopecia areata.

The treatments tried did not work for her alopecia areata.

Spironolactone is effective and safe for treating acne in women, especially those over 25 with hormonal imbalances.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Fenugreek seeds and Butea monosperma flowers may help reduce hair loss from chemotherapy.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The document's conclusion cannot be provided because the content is not in a processable format.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Residents improved their understanding and skills in using riverbank plants as medicine.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Unable to provide a summary as the document content is not provided.